incTANK Ventures

Tiba is a Boston based pre-clinical biotechnology company with a mission to create a new generation of vaccines and immunotherapies for human and animal disease. they bridge expertise in synthetic biology and chemistry to bring more potent and cost-effective solutions to the market. their vision is a world where affordable vaccines and therapeutics can be developed in response to epidemics and specific patient needs, without the need for protracted biomanufacturing processes.

Elemental Machines is revolutionizing science-based industries with a smart lab platform that offers powerful, data-driven insights to improve laboratory operations, research, development, and manufacturing outcomes. Continuously monitoring equipment and environmental variables provides new levels of clarity, transparency, consistency, and improved repeatability and gathers new data sets for advanced analytics.

Misfit is focused on developing great wearable products: things that people would want to wear all the time for a long time. A pioneer in the emerging world of wearable sensor technology, the company is making products and services in the consumer health and fitness space to inspire people to be more active and develop healthy habits. Misfit’s first product is the Shine, an elegant personal activity tracker that can instantly sync with a smartphone just by placing the device on the screen. Misfit was founded in 2011 and headquartered in Burlingame, California.

Ligon Discovery's primary technology platform, Small-Molecule Microarrays (SMMs), fundamentally transforms drug discovery by bringing the power of microarrays to target screening. SMMs, developed at Harvard University and the Broad Institute, use a proprietary surface chemistry to attach unmodified chemical collections to a solid surface, enabling massively-parallel screening against protein targets of any function. The scale and scope of SMMs permit a paradigmatic change in drug discovery strategy as entire protein families, molecular pathways, and even genome-wide target sets can be screened in parallel to rapidly identify small molecules with optimal characteristics for drug development. Ligon is applying SMM technology to challenging, novel targets aimed at discovery of first-in-class drugs for oncology and other selected diseases. Ligon Discovery's SMM platform is available for drug discovery collaborations.

Agrivida creates an enzyme solution to improve poultry and swine nutrition. GRAINZYME technology from Agrivida is an innovative platform that produces enzymes inside a corn kernel. By simply replacing a small amount of corn, it is a natural, convenient, and profitable way to introduce beneficial enzymes such as phytase, glucanase, and other enzymes into animal diets.

AgaMatrix develops and manufactures a line of diabetes products designed to improve the quality of diabetes care. The company’s products feature WaveSense, a new technology that personalizes each test to provide world class accuracy. It detects and corrects for many errors caused by differences in blood samples and environmental conditions. Zero-Click™, the WaveSense diabetes data management system, was designed to simplify data download. WaveSense and Zero-Click consist of six FDA-cleared products and are protected by a suite of more than 160 patents worldwide.

Agrivida creates an enzyme solution to improve poultry and swine nutrition. GRAINZYME technology from Agrivida is an innovative platform that produces enzymes inside a corn kernel. By simply replacing a small amount of corn, it is a natural, convenient, and profitable way to introduce beneficial enzymes such as phytase, glucanase, and other enzymes into animal diets.